Radiotherapy: Intermediate-risk endometrial cancer - Adjuvant treatment

Nature Reviews Clinical Oncology

Volumn 7, Issue 10, 2010, Pages 553-554

  Eifel, Patricia J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL TRIAL; ENDOMETRIUM CANCER; HIGH RISK PATIENT; HUMAN; HYSTERECTOMY; PRIORITY JOURNAL; SHORT SURVEY; UTERUS CARCINOMA;

BRACHYTHERAPY; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; NEOPLASM RECURRENCE, LOCAL; PELVIS; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS;

EID: 77957569823     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2010.138     Document Type: Short Survey

References (8)

1. Nout, R. A. et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet 375, 816-823 (2010).
2. Aalders, J., Abeler, V., Kolstad, P. & Onsrud, M. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet. Gynecol. 56, 419-427 (1980).
3. Creutzberg, C. L. et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 355, 1404-1411 (2000).
4. Keys, H. M. et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol. Oncol. 92, 744-751 (2004).
5. Creasman, W. et al. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 60, 2035-2041 (1987).
6. Kadar, N., Malfetano, J. H. & Homesley, H. D. Determinants of survival of surgically staged patients with endometrial carcinoma histologically confined to the uterus: implications for therapy. Obstet. Gynecol. 80, 655-659 (1992).
7. Morrow, C. et al. Relationship between surgicalpathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group Study. Gynecol. Oncol. 40, 55-65 (1991).
8. Hendrickson, M. et al. Adenocarcinoma of the endometrium: analysis of 256 cases with carcinoma limited to the uterine corpus. Pathology review and analysis of prognostic variables. Gynecol. Oncol. 13, 373-392 (1982).